[go: up one dir, main page]

AU5958000A - Method to improve viral infection - Google Patents

Method to improve viral infection

Info

Publication number
AU5958000A
AU5958000A AU59580/00A AU5958000A AU5958000A AU 5958000 A AU5958000 A AU 5958000A AU 59580/00 A AU59580/00 A AU 59580/00A AU 5958000 A AU5958000 A AU 5958000A AU 5958000 A AU5958000 A AU 5958000A
Authority
AU
Australia
Prior art keywords
viral infection
improve viral
improve
infection
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59580/00A
Inventor
Connie Jean Eaves
Burkhard Hennemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5958000A publication Critical patent/AU5958000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU59580/00A 1999-07-08 2000-07-07 Method to improve viral infection Abandoned AU5958000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34966499A 1999-07-08 1999-07-08
US09349664 1999-07-08
PCT/CA2000/000803 WO2001004332A1 (en) 1999-07-08 2000-07-07 Method to improve viral infection

Publications (1)

Publication Number Publication Date
AU5958000A true AU5958000A (en) 2001-01-30

Family

ID=23373426

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59580/00A Abandoned AU5958000A (en) 1999-07-08 2000-07-07 Method to improve viral infection

Country Status (2)

Country Link
AU (1) AU5958000A (en)
WO (1) WO2001004332A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection
JPH07289249A (en) * 1994-04-26 1995-11-07 Bio Material Kenkyusho:Kk Medium for neurocyte and method for culturing the same
KR100506569B1 (en) * 1995-09-29 2005-12-26 인디아나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Methods of Enhancing Virus-Mediated DNA Delivery Using Molecules Having Virus- and Cell-Binding Domains
EP0870839B1 (en) * 1995-11-13 2006-05-10 Takara Bio Inc. Method for gene introduction into target cells by retrovirus

Also Published As

Publication number Publication date
WO2001004332A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU2171501A (en) Improvements relating to double-stranded rna inhibition
AU1854901A (en) Novel method
AU6697200A (en) Lyophilization method
AU1564001A (en) Method and arrangement relating to positioning
AU1285300A (en) Hiv vaccine
AU2448900A (en) Easy to remove overwrap
AU4278699A (en) Improvements to pushchairs
AUPP967999A0 (en) Viral variants
AU5827000A (en) Viral il-10 uses
AU2281601A (en) Treatment of viral infections using levovirinTM
AU5570899A (en) Purified human papillomavirus
AU1571801A (en) Improved fermentation process
AU2001292947A1 (en) Methods for inhibition of viral infection
AU6158700A (en) Vaccine
AU6904101A (en) Infection model
AU6583900A (en) Easy to remove adhesive sheets
AU6228899A (en) Spacer
AU2002224845A1 (en) Viral expression system
AU5873300A (en) Process to prepare exemestane
AU6551800A (en) Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
AU5811600A (en) Vaccine
AU5958000A (en) Method to improve viral infection
AU4957800A (en) Vaccine against isa virus
AU5274099A (en) Hiv vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase